Domov › Rak dojke › Kalifornija

Klinične študije za Rak dojke v Kalifornija

179 študij za Rak dojke išče udeležence na lokacijah v Kalifornija.

Mesta v Kalifornija

Uradno besedilo študije (angleško)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

University of San Diego Moores Cancer Center, La Jolla
UCLA Jonsson Comprehensive Cancer Center, Los Angeles
USC Norris Comprehensive Cancer Center, Los Angeles

Vključevanje udeležencevFaza 1/2

Starost 12 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT04585750

Distance-Based Exercise to Preserve Function and Prevent Disability

Kaiser Permanente Dublin, Dublin
Kaiser Permanente-Fremont, Fremont
Kaiser Permanente Fresno Orchard Plaza, Fresno
in še 10

Vključevanje udeležencev

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07059884

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Onco Inst of Hope and Innovation, Cerritos
City of Hope National Medical, Duarte
Providence Medical Foundation, Fullerton
in še 7

Vključevanje udeležencevFaza 3

Starost 18–100 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05827081

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
PCR Oncology, Arroyo Grande
AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
in še 20

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Starost 40–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05334069

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

City of Hope - Duarte Cancer Center, Duarte

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06760819

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

City of Hope, Duarte

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06172478

A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer

Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
Stanford Medicine Cancer Center, Stanford

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07701941

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

Oncology Institute, Long Beach
Cancer & Blood Research Center, Los Alamitos

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07102381

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

City of Hope Comprehensive Cancer Center, Duarte
University of California Los Angeles, Los Angeles
University of California San Diego Moores Cancer Center, San Diego

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06625775

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

Beverly Hills Cancer Center, Beverly Hills
MemorialCare Orange Coast Medical Center, Fountain Valley
City of Hope at Orange County Lennar Foundation Cancer Center, Irvine
in še 3

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06369285

Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.

City of Hope Medical Center, Duarte
City of Hope at Irvine Lennar, Irvine
City of Hope at Long Beach Elm, Long Beach
in še 1

Vključevanje udeležencevFaza 2

Starost 70 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT04305834

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

The Oncology Institute of Hope and Innovation, Cerritos
Ellison Medical Institute, Los Angeles
Valkyrie Clinical Trials, Los Angeles
in še 3

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT06324357

Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy

California Protons Cancer Therapy Center, San Diego

Vključevanje udeležencevFaza 3

Starost 19 in več · Ženske · Posodobljeno 29. sep. 2026 · NCT05856773

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Research Site, Duarte
Research Site, Los Angeles
Research Site, Newport Beach
in še 1

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT05877599

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

California Protons Cancer Therapy Center, San Diego

Vključevanje udeležencevFaza 2

Starost 50 in več · Ženske · Posodobljeno 29. sep. 2026 · NCT01766297

IKS014 in Advanced Solid Tumors That Express HER2

Hoag Memorial Hospital Presbyterian, Newport Beach

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT05872295

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Los Angeles Hematology Oncology Medical Group ( Site 0026), Los Angeles
Hoag Memorial Hospital Presbyterian ( Site 0025), Newport Beach

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07060807

A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer

Los Angeles Cancer Network, Los Angeles
Community Clinical Trials, Orange

Vključevanje udeležencevFaza 2

Starost 18 in več · Ženske · Posodobljeno 25. sep. 2026 · NCT07054190

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Roy and Patricia Disney Family Cancer Center ( Site 0055), Burbank
Community Cancer Institute ( Site 0100), Clovis
Providence Medical Foundation ( Site 0080), Fullerton
in še 4

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06966700

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

Providence Medical Foundation-Oncology ( Site 0020), Fullerton

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06312176

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Providence Medical Foundation, Eureka
Providence Medical Foundation, Santa Rosa

Vključevanje udeležencevFaza 3

Starost 60 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06377852

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Research Site, Fountain Valley
Research Site, Glendale
Research Site, Sacramento

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06103864

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

City of Hope, Duarte
UC San Diego Moores Cancer Center, La Jolla
UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07007559

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Kivu Trial Site, Santa Monica

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT07229313

A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer

Precision NextGen Oncology and Research Center (Investigational Site number USA-001), Beverly Hills

Vključevanje udeležencevFaza 1

Starost 18–80 · Ženske · Posodobljeno 23. sep. 2026 · NCT07401381

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Clinical Trial Site, Beverly Hills
Clinical Trial Site, La Jolla
Clinical Trial Site, Los Alamitos
in še 8

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07085767

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Marin Cancer Care, Greenbrae
Loma Linda University, Loma Linda
Cancer and Blood Research Center, Los Alamitos
in še 3

Vključevanje udeležencev

Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07214532

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Community Cancer Institute, Clovis
City of Hope, Duarte
Epic Care - Emeryville, Emeryville
in še 19

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07174336

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

City of Hope, Duarte
University of California, Los Angeles (UCLA), Santa Monica
Stanford University Medical Center, Stanford

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07114601

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

City of Hope, Duarte
City of Hope Orange County Lennar Foundation Cancer Center, Irvine
USC/Norris Comprehensive Cancer Center, Los Angeles
in še 1

Vključevanje udeležencevFaza 2

Starost 18 in več · Ženske · Posodobljeno 22. sep. 2026 · NCT07287098

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Hoag Memorial Hospital Presbyterian, Newport Beach
Stanford University Medical Center, Stanford

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07213791

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

Disney Family Cancer Center, Burbank
City of Hope, Corona
City of Hope Comprehensive Cancer Center, Duarte
in še 2

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT05894239

Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

University of California Irvine, Irvine
University of California Los Angeles, Los Angeles
University of California Davis, Sacramento
in še 2

Vključevanje udeležencevVabljeni zdravi prostovoljci

Starost 30–74 · Ženske · Posodobljeno 21. sep. 2026 · NCT02620852

Pulsed Electric Field Ablation for Metastatic Breast Cancer

University of California San Francisco, San Francisco

Vključevanje udeležencev

Starost 18 in več · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT07487844

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

University Of California - San Diego Moores Cancer Center, La Jolla
Cancer and Blood Specialty Clinic (CBSC), Los Alamitos
Cedar Sinai - Samuel Oschin Cancer Center, Los Angeles
in še 4

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT07173751

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

City of Hope, Duarte
City of Hope, Irvine, Irvine

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT07109726

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

Beverly Hills Cancer Center, Beverly Hills
Hoag Memorial Hospital Presbyterian, Newport Beach

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT06827236

ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health

UC Davis, Sacramento

Vključevanje udeležencevOpazovalna študija

Starost 18–94 · Ženske · Posodobljeno 17. sep. 2026 · NCT07505797

A Study of Breast Cancer Risk Factors and Outcomes of People in Florida

University of California, Los Angeles (Specimen Analysis only), Los Angeles

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT06780176

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

UCSF Cancer Center Berkeley, Berkeley
Cedars-Sinai Cancer Beverly Hills, Beverly Hills
City of Hope National Medical Center, Duarte
in še 19

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT06492616

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.